Vicore Pharma Holding AB (VCRE) Stock Forecast: StockMap's 2-Week Call

VCRE stock forecast: StockMap's model leans Underperform on Vicore Pharma Holding AB for the two weeks after the Nov 13 close, toward VCRE trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 5 two-week windows on VCRE since Aug 26; by chance, a call on the same dates was right 62% of the time.

Vicore Pharma Holding AB last closed at $10.36, -5.73% on the session.

Against the IVW growth benchmark the position is -4.82% over the forecast window.

Vicore Pharma Holding AB's market cap is $300.28M as of November 13, 2026.

Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -36 (too close to call).

Where VCRE sits: sized by market cap, coloured by the day's move.

The read is built from 12 underlying insights — 2 bullish and 10 bearish.

Agreement across those insights is 83%.

36 daily calls for VCRE so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Vicore Pharma Holding AB is classified under Health Care / Biotechnology.

StockMap tracks Vicore Pharma Holding AB as the 209th largest of the 391 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 186 Moderate Underperform, 157 Neutral, 33 Strong Underperform and 15 Moderate Outperform.

On that composite Vicore Pharma Holding AB ranks 288th of 391 in the group, against a group median of -0.24.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 13, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

Vicore Pharma Holding AB (VCRE) — StockMap 2-week forecast & tracked accuracy